» Articles » PMID: 6197596

Surgical Approaches to Cholangiocarcinoma at Confluence of Hepatic Ducts

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1984 Jan 14
PMID 6197596
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Analysis of the surgical management of 94 consecutive patients with carcinoma at the confluence of the hepatic ducts showed that 20% of them (or 60% of those thought, after comprehensive pre-operative investigation, to have resectable lesions) underwent tumour resection--6 local resections and 12 liver resections. The 30-day hospital mortality was 11% and mean duration of survival was 17 months (7 patients are still alive, with a mean survival of 22.2 months). The quality of life was also much improved after resection. In patients treated with palliative surgery the hospital mortality was 33% and the mean survival was 8.5 months. The results support the treatment of bile-duct carcinoma at the hilum of the liver by resection and suggest that the use of drainage techniques, whether employed surgically or non-surgically, be reserved until the possibility of treatment by resection has been fully considered.

Citing Articles

Parenchyma-preserving hepatectomy including segments I + IV resection and bile duct resection in a patient with type IV perihilar cholangiocarcinoma: A case report with video clip.

Hwang S Ann Hepatobiliary Pancreat Surg. 2021; 25(3):419-425.

PMID: 34402446 PMC: 8382862. DOI: 10.14701/ahbps.2021.25.3.419.


Standard and modified techniques for parenchyma-preserving hepatectomy focused on segments I+IV resection in patients with perihilar cholangiocarcinoma.

Hwang S Ann Hepatobiliary Pancreat Surg. 2021; 25(1):112-121.

PMID: 33649263 PMC: 7952662. DOI: 10.14701/ahbps.2021.25.1.112.


Fifty-year history of biliary surgery.

Nagino M Ann Gastroenterol Surg. 2019; 3(6):598-605.

PMID: 31788648 PMC: 6875948. DOI: 10.1002/ags3.12289.


Comparison analysis of left-side versus right-side resection in bismuth type III hilar cholangiocarcinoma.

Lee Y, Choi D, Han S, Han I, Heo J, Choi S Ann Hepatobiliary Pancreat Surg. 2018; 22(4):350-358.

PMID: 30588526 PMC: 6295382. DOI: 10.14701/ahbps.2018.22.4.350.


High dose chemoradiation for unresectable hilar cholangiocarcinomas using intensity modulated external beam radiotherapy: a single tertiary care centre experience.

Engineer R, Mehta S, Kalyani N, Chaudhari S, Dharia T, Shetty N J Gastrointest Oncol. 2017; 8(1):180-186.

PMID: 28280622 PMC: 5334046. DOI: 10.21037/jgo.2017.01.20.